201 related articles for article (PubMed ID: 31252430)
41. Conserved DNA motifs in the type II-A CRISPR leader region.
Van Orden MJ; Klein P; Babu K; Najar FZ; Rajan R
PeerJ; 2017; 5():e3161. PubMed ID: 28392985
[TBL] [Abstract][Full Text] [Related]
42. Repeat Size Determination by Two Molecular Rulers in the Type I-E CRISPR Array.
Goren MG; Doron S; Globus R; Amitai G; Sorek R; Qimron U
Cell Rep; 2016 Sep; 16(11):2811-2818. PubMed ID: 27626652
[TBL] [Abstract][Full Text] [Related]
43. Reproducible Antigen Recognition by the Type I-F CRISPR-Cas System.
Wiegand T; Semenova E; Shiriaeva A; Fedorov I; Datsenko K; Severinov K; Wiedenheft B
CRISPR J; 2020 Oct; 3(5):378-387. PubMed ID: 33095052
[TBL] [Abstract][Full Text] [Related]
44. Cas4-Cas1 Is a Protospacer Adjacent Motif-Processing Factor Mediating Half-Site Spacer Integration During CRISPR Adaptation.
Kieper SN; Almendros C; Haagsma AC; Barendregt A; Heck AJR; Brouns SJJ
CRISPR J; 2021 Aug; 4(4):536-548. PubMed ID: 34406043
[TBL] [Abstract][Full Text] [Related]
45. Identification of Spacer and Protospacer Sequence Requirements in the Vibrio cholerae Type I-E CRISPR/Cas System.
Bourgeois J; Lazinski DW; Camilli A
mSphere; 2020 Nov; 5(6):. PubMed ID: 33208517
[TBL] [Abstract][Full Text] [Related]
46. DNA binding specificities of Escherichia coli Cas1-Cas2 integrase drive its recruitment at the CRISPR locus.
Moch C; Fromant M; Blanquet S; Plateau P
Nucleic Acids Res; 2017 Mar; 45(5):2714-2723. PubMed ID: 28034956
[TBL] [Abstract][Full Text] [Related]
47. Selective loading and processing of prespacers for precise CRISPR adaptation.
Kim S; Loeff L; Colombo S; Jergic S; Brouns SJJ; Joo C
Nature; 2020 Mar; 579(7797):141-145. PubMed ID: 32076262
[TBL] [Abstract][Full Text] [Related]
48. CRISPR-Cas systems in multicellular cyanobacteria.
Hou S; Brenes-Álvarez M; Reimann V; Alkhnbashi OS; Backofen R; Muro-Pastor AM; Hess WR
RNA Biol; 2019 Apr; 16(4):518-529. PubMed ID: 29995583
[TBL] [Abstract][Full Text] [Related]
49. Protecting genome integrity during CRISPR immune adaptation.
Wright AV; Doudna JA
Nat Struct Mol Biol; 2016 Oct; 23(10):876-883. PubMed ID: 27595346
[TBL] [Abstract][Full Text] [Related]
50. Characterizing leader sequences of CRISPR loci.
Alkhnbashi OS; Shah SA; Garrett RA; Saunders SJ; Costa F; Backofen R
Bioinformatics; 2016 Sep; 32(17):i576-i585. PubMed ID: 27587677
[TBL] [Abstract][Full Text] [Related]
51. Foreign DNA capture during CRISPR-Cas adaptive immunity.
Nuñez JK; Harrington LB; Kranzusch PJ; Engelman AN; Doudna JA
Nature; 2015 Nov; 527(7579):535-8. PubMed ID: 26503043
[TBL] [Abstract][Full Text] [Related]
52. CRISPR adaptation biases explain preference for acquisition of foreign DNA.
Levy A; Goren MG; Yosef I; Auster O; Manor M; Amitai G; Edgar R; Qimron U; Sorek R
Nature; 2015 Apr; 520(7548):505-510. PubMed ID: 25874675
[TBL] [Abstract][Full Text] [Related]
53. Cas4 Nucleases Define the PAM, Length, and Orientation of DNA Fragments Integrated at CRISPR Loci.
Shiimori M; Garrett SC; Graveley BR; Terns MP
Mol Cell; 2018 Jun; 70(5):814-824.e6. PubMed ID: 29883605
[TBL] [Abstract][Full Text] [Related]
54. CRISPR Content Correlates with the Pathogenic Potential of Escherichia coli.
García-Gutiérrez E; Almendros C; Mojica FJ; Guzmán NM; García-Martínez J
PLoS One; 2015; 10(7):e0131935. PubMed ID: 26136211
[TBL] [Abstract][Full Text] [Related]
55. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
[TBL] [Abstract][Full Text] [Related]
56. Spermidine strongly increases the fidelity of
Plateau P; Moch C; Blanquet S
J Biol Chem; 2019 Jul; 294(29):11311-11322. PubMed ID: 31171718
[TBL] [Abstract][Full Text] [Related]
57. CRISPR DNA elements controlling site-specific spacer integration and proper repeat length by a Type II CRISPR-Cas system.
Kim JG; Garrett S; Wei Y; Graveley BR; Terns MP
Nucleic Acids Res; 2019 Sep; 47(16):8632-8648. PubMed ID: 31392984
[TBL] [Abstract][Full Text] [Related]
58. DnaQ exonuclease-like domain of Cas2 promotes spacer integration in a type I-E CRISPR-Cas system.
Drabavicius G; Sinkunas T; Silanskas A; Gasiunas G; Venclovas Č; Siksnys V
EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29891635
[TBL] [Abstract][Full Text] [Related]
59. Allosteric regulation in CRISPR/Cas1-Cas2 protospacer acquisition mediated by DNA and Cas2.
Long C; Dai L; E C; Da LT; Yu J
Biophys J; 2021 Aug; 120(15):3126-3137. PubMed ID: 34197800
[TBL] [Abstract][Full Text] [Related]
60. CRATES: A one-step assembly method for Class 2 CRISPR arrays.
Liao C; Slotkowski RA; Beisel CL
Methods Enzymol; 2019; 629():493-511. PubMed ID: 31727255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
